New nose spray could help diabetic eye disease when shots fail
NCT ID NCT06881888
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 27 times
Summary
This early-stage study tests a drug called octreotide, given as a nose spray, for people with diabetic macular edema (swelling in the back of the eye) that hasn't improved with standard treatments. The goal is to see if the spray is safe and can reduce swelling and improve vision. About 60 adults aged 18 to 90 will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Alabama at Birmingham
Birmingham, Alabama, 35243, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.